Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for

Authors :: Marcus A, Mall
Rossa, Brugha
Silvia, Gartner
Julian, Legg
Alexander, Moeller
Pedro, Mondejar-Lopez
Dario, Prais
Tacjana, Pressler
Felix, Ratjen
Philippe, Reix
Paul D, Robinson
Hiran, Selvadurai
Florian, Stehling
Neil, Ahluwalia
Emilio, Arteaga-Solis
Bote G, Bruinsma
Mark, Jennings
Samuel M, Moskowitz
Sabrina, Noel
Simon, Tian
Tanya G, Weinstock
Pan, Wu
Claire E, Wainwright
Jane C, Davies
Source :: American journal of respiratory and critical care medicine. 206(11)
Publication Year :: 2022

Subjects :: Cystic Fibrosis
Forced Expiratory Volume
Mutation
Humans
Cystic Fibrosis Transmembrane Conductance Regulator
Benzodioxoles
Child
Aminophenols
Chloride Channel Agonists

Tools